From High Cost to High Access: The Impact of Generic Abiraterone on Medicare Part D Spending in Advanced Prostate Cancer
Urology Practice | August 4, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
10.1097/upj.0000000000001066
| PMID 42550948